|
|
|
|
A more recent version of this article appeared on March 1, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 18, 2004
Accepted on December 16, 2004
Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27157
Monitoring Editor: Gerard Evan
Although evasion of apoptosis is thought to be required for the development of cancer, it is unclear which cell death pathways are evaded. We previously identified a novel epithelial cell death pathway that works in normal cells but is inactivated in tumor cells implying that it may be targeted during tumor development. The pathway can be activated by the death domain of the adaptor protein FADD but is distinct from the known mechanism of FADD-induced apoptosis through caspase-8. Here we show that a physiological signal (Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand, TRAIL) can kill normal epithelial cells through the endogenous FADD protein using the novel FADD death domain pathway, which activates both apoptosis and autophagy. We also show that selective resistance to this pathway occurs when primary epithelial cells are immortalized and that this occurs through a mechanism that is independent of known events (telomerase activity, and loss of function of p53, Rb, INK4a and ARF) that are associated with immortalization. These data identify a novel cell death pathway that combines apoptosis and autophagy and is selectively inactivated at the earliest stages of epithelial cancer development.
Corresponding author.
E-mail: Andrew.Thorburn{at}uchsc.edu
This article has been cited by other articles:
![]() |
K. Nishida, O. Yamaguchi, and K. Otsu Crosstalk Between Autophagy and Apoptosis in Heart Disease Circ. Res., August 15, 2008; 103(4): 343 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mizushima Autophagy: process and function Genes & Dev., November 15, 2007; 21(22): 2861 - 2873. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-J. Park, S.-H. Lee, T.-I. Kim, H.-W. Lee, C.-H. Lee, E.-H. Kim, J.-Y. Jang, K. S. Choi, M.-H. Kwon, and Y.-S. Kim A Human scFv Antibody against TRAIL Receptor 2 Induces Autophagic Cell Death in Both TRAIL-Sensitive and TRAIL-Resistant Cancer Cells Cancer Res., August 1, 2007; 67(15): 7327 - 7334. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Gaddy and D. S. Lyles Oncolytic Vesicular Stomatitis Virus Induces Apoptosis via Signaling through PKR, Fas, and Daxx J. Virol., March 15, 2007; 81(6): 2792 - 2804. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Jennings Jr., J.-h. Zhu, Y. Rbaibi, X. Luo, C. T. Chu, and K. Kiselyov Mitochondrial Aberrations in Mucolipidosis Type IV J. Biol. Chem., December 22, 2006; 281(51): 39041 - 39050. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Hippert, P. S. O'Toole, and A. Thorburn Autophagy in Cancer: Good, Bad, or Both? Cancer Res., October 1, 2006; 66(19): 9349 - 9351. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lavieu, F. Scarlatti, G. Sala, S. Carpentier, T. Levade, R. Ghidoni, J. Botti, and P. Codogno Regulation of Autophagy by Sphingosine Kinase 1 and Its Role in Cell Survival during Nutrient Starvation J. Biol. Chem., March 31, 2006; 281(13): 8518 - 8527. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Guo, C. Chen, Y. Zheng, J. Zhang, X. Tao, S. Liu, D. Zheng, and Y. Liu A Novel Anti-human DR5 Monoclonal Antibody with Tumoricidal Activity Induces Caspase-dependent and Caspase-independent Cell Death J. Biol. Chem., December 23, 2005; 280(51): 41940 - 41952. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yang, J. Wang, C. Liu, W. E. Grizzle, S. Yu, S. Zhang, S. Barnes, W. J. Koopman, J. D. Mountz, R. P. Kimberly, et al. Cleavage of p53-Vimentin Complex Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Apoptosis of Rheumatoid Arthritis Synovial Fibroblasts Am. J. Pathol., September 1, 2005; 167(3): 705 - 719. [Abstract] [Full Text] [PDF] |
||||